Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial

被引：20

作者：

Kater, Arnon P. ^{[1
]}

Christensen, Jacob Haaber ^{[2
]}

Bentzen, Hans Herluf ^{[3
]}

Niemann, Carsten Utoft ^{[4
]}

Hutchings, Martin ^{[4
]}

Chen, Jenny ^{[5
]}

Rios, Marcia ^{[6
]}

Palenski, Tammy ^{[6
]}

Li, Tommy ^{[5
]}

Mato, Anthony R. ^{[7
]}

机构：

[1] Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands

[2] Odense Univ Hosp, Odense, Denmark

[3] Aarhus Univ Hosp, Aarhus, Denmark

[4] Copenhagen Univ Hosp, Rigshospitalet, Copenhagen, Denmark

[5] Genmab, Princeton, NJ USA

[6] AbbVie, N Chicago, IL USA

[7] Mem Sloan Kettering Canc Ctr, Chron Lymphocyt Leukemia Program, New York, NY USA

来源：

关键词：

D O I：

10.1182/blood-2021-146563

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2627

引用

页数：4